AbbVie competitors

AbbVie's competitors include MyoKardia, GlaxoSmithKline, Novartis, Roche and Johnson & Johnson
Add company...
AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
GlaxoSmithKline
GlaxoSmithKline is a science-led healthcare company.
Novartis
Novartis provides healthcare solutions that address the evolving needs of patients and societies.
Roche
Roche Holding is a diagnostics and pharmaceutical company.
Johnson & Johnson
Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Founding Date
Founding Date
2013
Founding Date
2012
Founding Date
2000
Founding Date
1996
Founding Date
1896
Founding Date
1886
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
North Chicago, US HQ
Ludwigshafen, DE
Sligo, IE
Cork, IE
Campoverde, IT
Tokyo, JP
Jayuya, PR
see more
Locations
South San Francisco, US HQ
Locations
Brentford, GB HQ
Locations
Basel, CH HQ
Beijing, CN
Wehr, DE
Tokyo, JP
New York, US
East Hanover, US
Locations
Basel, CH HQ
South San Francisco, US
Locations
New Brunswick, US HQ
Dhaka, BD
Machelen, BE
Suzhou, CN
New Delhi, IN
see more
Employees
Employees
29,000
Employees
1024% increase
Employees
98,462
Employees
126,0004% increase
Employees
93,734
Employees
134,000
Valuation ($)
Valuation ($)
148.7 b
Valuation ($)
2.3 b
Valuation ($)
101.9 b
Valuation ($)
175.5 b
Valuation ($)
N/A
Valuation ($)
355.4 b
Facebook likes
Facebook likes
11.9 k
Facebook likes
N/A
Facebook likes
273 k
Facebook likes
304.3 k
Facebook likes
80.2 k
Facebook likes
776.4 k
Twitter followers
Twitter followers
48.3 k
Twitter followers
387
Twitter followers
163.4 k
Twitter followers
234.4 k
Twitter followers
177.2 k
Twitter followers
90.5 k

Financial

Revenue (est.)
Revenue (est.)
$25.6b (FY, 2016)
Revenue (est.)
$22.5m (FY, 2017)
Revenue (est.)
£30.2b (FY, 2017)
Revenue (est.)
$48.5b (FY, 2016)
Revenue (est.)
CHF48.1b (FY, 2015)
Revenue (est.)
$76.5b (FY, 2017)
Cost of goods
Cost of goods
$5.8b (FY, 2016)
Cost of goods
N/A
Cost of goods
£10.3b (FY, 2017)
Cost of goods
$17.5b (FY, 2016)
Cost of goods
CHF15.5b (FY, 2015)
Cost of goods
$25.4b (FY, 2017)
Gross profit
Gross profit
$19.8b (FY, 2016)
Gross profit
N/A
Gross profit
£19.8b (FY, 2017)
Gross profit
$31b (FY, 2016)
Gross profit
CHF32.7b (FY, 2015)
Gross profit
$51.1b (FY, 2017)
Net income
Net income
$6b (FY, 2016)
Net income
($46m) (FY, 2017)
Net income
£2.2b (FY, 2017)
Net income
$6.7b (FY, 2016)
Net income
CHF9.1b (FY, 2015)
Net income
$1.3b (FY, 2017)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
100 (FY, 2016)
Countries
N/A
Countries
N/A
Countries
60 (FY, 2017)
Drugs Approved by FDA
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
2 (Y, 2015)
Drugs Approved by FDA
2 (FY, 2015)
Major Approvals (US, EU, JP)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
16 (Y, 2016)
Major Approvals (US, EU, JP)
12 (Y, 2016)
Major Approvals (US, EU, JP)
N/A
Manufacturing Facilities
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
87 (FY, 2016)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
125 (FY, 2017)
US FDA Breakthrough Therapy Designations
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
5 (Y, 2016)
US FDA Breakthrough Therapy Designations
5 (Y, 2016)
US FDA Breakthrough Therapy Designations
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 98m
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
GlaxoSmithKline
HQ
Brentford, GB
Employees
98,462

GlaxoSmithKline is a science-led healthcare company.

View company
Novartis
HQ
Basel, CH
Employees
126,000↑ 4% increase

Novartis provides healthcare solutions that address the evolving needs of patients and societies.

View company
Roche
HQ
Basel, CH
Employees
93,734

Roche Holding is a diagnostics and pharmaceutical company.

View company